Informativa

Questo sito o gli strumenti terzi da questo utilizzati si avvalgono di cookie necessari al funzionamento ed utili alle finalità illustrate nella cookie policy. Se vuoi saperne di più o negare il consenso a tutti o ad alcuni cookie, consulta la cookie policy.
Chiudendo questo banner, scorrendo questa pagina, cliccando su un link o proseguendo la navigazione in altra maniera, acconsenti all’uso dei cookie.

NATO to fly

 

 

NATO Experiment logo

Pavia/Livorno, 1 Apr 2015 - After the successful start of the "Stem Celle Differentiation" (SCD) experiment, another italian experiment is going on board the International Space Station: NATO, "Nanoparticles and Osteoporosis". Directed by Doct. Livia Visai of University of Pavia, the experiment is focuesd on the development of a nanotechnology as countermeasure for the effect of the microgravity on the astronaut bone tissues and, then, on the development of new therapies against the osteoporosis on ground.

The teams of the University of Pavia and of Kayser Italia are leaving for the NASA Kennedy Space Center (Florida) where the experiments cells will be prepared and boarded on the Spacex-6 capsule to be launched not-early-than the next April, 8th.

Follow the mission activities on the University of Pavia 's blog.

 

 


 

 

T-Cell Activation in Aging - Second flight

 


Cape Canaveral, Florida – On January 10th SpaceX successfully conducted a second attempt to launch its Falcon 9 rocket, tasked with sending the CRS-5/SpX-5 Dragon spacecraft to the International Space Station. A total of 577 kilograms (1,272 lb) of scientific hardware is being carried within the Dragon capsule. Among them, the ”T-Cell Activation in Aging  - Second flight” experiment developed by Kayser Italia in the frame of an ESA-NASA cooperation. This experiment is the second flight in a two-part investigation. The first T-Cell Activation in Aging experiment flew to the International Space Station aboard SpaceX-3 on April 18, 2014. For this second experiment flight, Kayser Italia was commissioned by ESA to provide the experiment units and containers, as well as to support all ground and pre-launch/return activities. The experiment investigates the early molecular pathway involved in the human immune system depression in space, a phenomena that occur during aging but also while the astronauts are in microgravity conditions. The launch, initially planned on December, 16th , due to several technical reasons was delayed to December, 19th, then to January, 6th and finally to January, 10th. Two teams of Kayser Italia specialists supported all these pre-launch activities.

More information are available on the press release NIH-1a: A Biology experiment for the ISS 

Past news:

 


 

Stem Cell Differentiation (SCD) ready to start

Stem Cell Differentiation (SCD) ready to start 


Soyuz mission 42S (Credit Kayser Italia)

Baikonur (Kazakhstan), 25 Mar 2015 - The Kayser Italia team at the Baikonur cosmodrome informed that everything is progressing well for the launch that will bring the "Stem Cell Differentiation" experiment (SCD) on board the International Space Station. The rocket has been successfully erected and the team is working on the preparation of the biological samples that will be loaded only few hours before the launch, actually scheduled for Mar, 28th 2015. 

Once on board, the SCD experiment will be operated by our astronaut Samantha Cristoforetti in the ISS Columbus module. The Kayser Italia experiment units will be inserted in the Kubik facility where will be kept at a constant temperature of 37°C. The facility will be powered by the Kayser Italia's Portable Power Supply (PPS), serving many European experiments on board the station since 2012. When completed the SCD experiment units will be kept at low temperature till they will return to ground with the Soyuz 41S together with Samantha Cristoforetti. The return is currently scheduled for May, 13th 2015.

The SCD experiment (The Principal Investigator is Dr. Silvia Bradamante, CNR, Milan) will investigate on the muscle-skeleton and aging problems that occur on the human body when in space. Experiment results could have important Earth implications on the study of the osteoporosis.


 

Aging Research has more Space

 

Cape Canaveral, Florida – On April, 18th  the SpaceX Falcon 9 rocket had been successfully launched, placing the Dragon capsule on the way for the International Space Station. The capsule, among the over-2-tons of supplies and scientific material, also transported the ”T-Cell Activation in Aging”, an experiment developed by Kayser Italia in the frame of an ESA-NASA cooperation. In particular, Kayser Italia was commissioned by ESA to provide the experiment units and containers, as well as to support all ground and pre-launch/return activities. The experiment investigates the early molecular pathway involved in the human immune system depression in space, a phenomena that occur during aging but also while the astronauts are in microgravity conditions. 

During the in-orbit operations the samples had been placed in the KUBIK incubator in the European Columbus module, at  a temperature of 37° C. Finally, after a predefined period, the NASA astronaut Ricky Mastracchio performed both the cell activations and the sample fixation. On Monday April, 21st At 19:45 CET the samples have been safely stored in the MELFI, the station on-board freezer. The NIH samples will remain at a controlled temperature till the re-entry on Earth of the Dragon capsule, actually scheduled at May, 18th 2014. 

The mission, also known as CRS-3, is the third SpaceX Cargo Resupply Mission to the International Space Station. The launch, initially planned on March, 12th , was delayed a few times due to several technical reasons. A team of Kayser Italia specialists supported all these pre-launch activities.

More information are available on the press release NIH-1a: A Biology experiment for the ISS 

Past news:

 


 

Copyright